What to Expect From Nutrien’s Upcoming Q1 Earnings Results?
<p>RBC Capital analysts provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/NTR'>Nutrien (NYSE:NTR)</a>, expecting a weak Q1 (scheduled on May 10) and 2023 downward guidance revisions, reflecting a slow start to 2023. RBC Capital estimates quarterly EBITDA of $1.6 billion, compared to the Street estimate of $1.7 billion.</p>
<p>Demand was slower than expected through Q1, despite favorable ag/fertilizer fundamentals, resulting in continued price declines and slow sales. Nitrogen performed worse than anticipated, and there was also a decline in potash.</p>
<p>The analysts lowered their 2023 and 2024 EBITDA estimates to $8.1 billion and $7.9 billion, from $9.0 billion and $8.7 billion, and cut their price target to $100 from $110.</p>


NYSE:NTR